ArticleTrends in molecular medicine2022
Communicating science and protecting scientists in a time of political instability.
Article in Trends in molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Control of companion animal parasites and impact on One Health.One health (Amsterdam, Netherlands) · 2024Review
- Confronting the evolution and expansion of anti-vaccine activism in the USA in the COVID-19 era.Lancet (London, England) · 2023Review
- Global Vaccinations: New Urgency to Surmount a Triple Threat of Illness, Antiscience, and Anti-Semitism.Rambam Maimonides medical journal · 2023Article
- Wonder of wonders, miracle of miracles: the unprecedented speed of COVID-19 science.Physiological reviews · 2022Article
- Optimizing Missouri's Preparation for the Next Pandemic: Lessons Learned from COVID-19: Part 1.Missouri medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The coronavirus disease 2019 (COVID-19) pandemic will change how we communicate biomedical science to reflect the new realities of increasing politicization of vaccines or therapeutics, as well as targeted attacks against prominent US scientists. The stakes are high, given how thousands of Americans are losing their lives by refusing vaccinations or demanding unproven treatments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.